Chemotherapy News and Research

Latest Chemotherapy News and Research

Virtual or in person: Which kind of doctor’s visit is better, and when it matters

When the covid-19 pandemic swept the country in early 2020 and emptied doctors' offices nationwide, telemedicine was suddenly thrust into the spotlight. Patients and their physicians turned to virtual visits by video or phone rather than risk meeting face-to-face.

6 Mar 2023

Discovery about cell membrane 'blebs' could lead to new ways to fight melanoma

Cell membrane protrusions called blebs that typically signify the end of life for healthy cells do the opposite for melanoma cells, activating processes in these cells that help them to survive and spread, a UT Southwestern study suggests.

3 Mar 2023

Quiescent ovarian cancer cells secrete a protein to induce chemotherapy resistance in neighboring cells

Certain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, according to a new study from University of Pittsburgh and UPMC researchers that may help explain why ovarian cancer patients respond poorly to chemotherapy or relapse after treatment.

3 Mar 2023

California’s massive Medicaid program works for some, but fails many others

Newborns. Former inmates. College students. Expectant moms. People with disabilities. Foster kids. Homeless people. Single dads.

2 Mar 2023

What is the role of B cells in breast cancer pathology?

In a recent study published in Cancers, researchers comprehensively summarized all available information about B cells in the context of breast cancer.

1 Mar 2023

Chemotherapy affects the cellular landscape of tumor microenvironment in pancreatic cancer

Chemotherapy affects the ability of a patient's immune system to attack pancreatic tumors, a new study shows.

1 Mar 2023

Largest genomic study focuses on the prognosis of metastatic pheochromocytomas

Pheochromocytoma is a rare tumor, with an incidence of three to eight cases per million population per year.

28 Feb 2023

Applying an evolutionary perspective to medicine can spark biomedical innovations

The word 'evolution' may bring to mind dusty dinosaur bones, but it impacts our health every day. For example, even though antibiotics were invented only a century ago, the evolution of antibiotic resistance is already a major concern.

28 Feb 2023

Microglia may be the culprit behind concentration and memory problems after chemotherapy

Immune cells that keep the brain free of debris but also contribute to inflammation are the likely culprits behind the concentration and memory problems that sometimes follow one type of chemotherapy, a new study in mice suggests.

28 Feb 2023

Inexpensive combo-chemotherapy found to be better tolerated than BCG for common bladder cancer

An on-going, worldwide shortage of bacillus Calmette-Guérin (BCG) means that many patients with a common and serious type of bladder cancer have limited access to this effective standard of care treatment.

28 Feb 2023

Growing use of immunotherapy linked to increase in Medicare spending for outpatient terminal cancer care

A new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives were driven almost entirely by a type of treatment given to fewer than 1 in 5 patients.

27 Feb 2023

Definition of low-risk WNT-pathway medulloblastoma may need to be refined, say experts

A new research perspective was published in Oncotarget's Volume 14 on February 7, 2023, entitled, "WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?"

27 Feb 2023

Exploring the immunomodulatory and anti-inflammatory properties of butyrate

In a recent study published in the journal Fermentation, researchers reviewed studies examining the role of butyrate in inflammatory responses, immunological properties, and diseases related to the immune system such as atopic dermatitis, systemic lupus erythematosus, human immunodeficiency virus (HIV), psoriasis, and cancer.

24 Feb 2023

Study identifies a potential new targeted drug for treating acute myeloid leukemia

Targeted drugs have been developed to supplement chemotherapy in the treatment of cancer. These drugs only affect cancer cells, leaving healthy cells alone.

23 Feb 2023

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Mistletoe extract has been widely used to support cancer therapy and improve quality of life, but there has been a lack of clinical trials and data to support its use.

22 Feb 2023

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

To create the most effective, personalized treatment plans for patients with Hodgkin lymphoma or other cancers, scientists and clinicians need the clearest picture of the genetic changes leading to the cancer's development.

21 Feb 2023

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Patients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to have more-aggressive tumors and significantly lower overall survival (OS) than those in higher-income neighborhoods, according to research led by Roswell Park Comprehensive Cancer Center.

21 Feb 2023

Private hospitals massively underused in many areas of the UK during the pandemic

Private hospitals were paid around £2bn to help the NHS during the first year of the covid pandemic. But an investigation by The BMJ has found that just 30 of the 200 private hospitals were used to treat patients with covid-19 in April 2020 when the first pandemic wave hit its peak.

17 Feb 2023

Proposal to scrap England’s long term plan for cancer could cost lives, experts warn

The UK government's proposal to roll England's long term plan for cancer into one strategy covering all major conditions, such as cardiovascular disease, chronic respiratory disease, dementia, mental health conditions, and musculoskeletal disorders is "a catastrophic decision that will cost lives," warn experts in The BMJ today.

17 Feb 2023

The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals

Researchers determined the prevalence of antibodies against the SARS-CoV-2 spike glycoprotein following three or more doses of COVID-19 vaccines among immunocompromised individuals.

17 Feb 2023

Chemotherapy News and Research

Latest Chemotherapy News and Research

Virtual or in person: Which kind of doctor’s visit is better, and when it matters

Discovery about cell membrane 'blebs' could lead to new ways to fight melanoma

Quiescent ovarian cancer cells secrete a protein to induce chemotherapy resistance in neighboring cells

California’s massive Medicaid program works for some, but fails many others

What is the role of B cells in breast cancer pathology?

Chemotherapy affects the cellular landscape of tumor microenvironment in pancreatic cancer

Largest genomic study focuses on the prognosis of metastatic pheochromocytomas

Applying an evolutionary perspective to medicine can spark biomedical innovations

Microglia may be the culprit behind concentration and memory problems after chemotherapy

Inexpensive combo-chemotherapy found to be better tolerated than BCG for common bladder cancer

Growing use of immunotherapy linked to increase in Medicare spending for outpatient terminal cancer care

Definition of low-risk WNT-pathway medulloblastoma may need to be refined, say experts

Exploring the immunomodulatory and anti-inflammatory properties of butyrate

Study identifies a potential new targeted drug for treating acute myeloid leukemia

First phase I trial of intravenous mistletoe extract to treat advanced cancer

Whole genome sequencin provides clearest picture of the genetic changes leading to Hodgkin lymphoma

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Private hospitals massively underused in many areas of the UK during the pandemic

Proposal to scrap England’s long term plan for cancer could cost lives, experts warn

The prevalence of spike-protein antibodies following at least 3 COVID-19 vaccine doses in immunocompromised individuals

Cancer Research - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in